Potential alternative approaches for obtaining more insulin producing cells for the treatment of diabetes include proliferation of existing β-cells, differentiation from adult endocrine progenitor cells or embryonic stem cells, and reprogramming of non-β-cells such as acinar or liver cells to β-cells [18]. This evidence concerns the gene INS and diabetes mellitus.